Approaches to prolong the use of uncuffed hemodialysis catheters: Results of a randomized trial

American Journal of Nephrology

Volumn 33, Issue 3, 2011, Pages 260-268

  Filiopoulos, Vassilis ^a   Hadjiyannakos, Dimitrios ^a   Koutis, Ioannis ^a   Trompouki, Sofia ^a   Micha, Theodora ^a   Lazarou, Dimitrios ^a   Vlassopoulos, Dimosthenis ^a  

^a AMALIA FLEMING GENERAL HOSPITAL   (Greece)

Author keywords

Catheter related bacteremia; Hemodialysis; Lock solutions; Taurolidine; Thrombosis; Uncuffed catheters

Indexed keywords

CITRIC ACID; GENTAMICIN; HEPARIN; TAUROLIDINE;

ADULT; AGED; ARTICLE; BACTEREMIA; CATHETER RELATED BACTEREMIA; CATHETER THROMBOSIS; DIALYSIS CATHETER; DISEASE FREE SURVIVAL; ENTEROCOCCUS FAECALIS; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS INFECTION; UNCUFFED CATHETER;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CITRIC ACID; FEMALE; GENTAMICINS; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TAURINE; THIADIAZINES;

EID: 79952106935     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324685     Document Type: Article

References (26)

1. Beathard GA, Urbanes A: Infection associ-ated with tunneled hemodialysis catheters. Semin Dial 2008; 21: 528-538.
2. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros A, Tordoir J, Van Biesen W: Diagnosis, prevention and treat-ment of hemodialysis catheter-related blood-stream infections: a position statement of European Renal Best Practice. NDT Plus 2010; 3: 234-246.
3. Pisoni RL, Young EW, Dykstra DM, Green-wood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002; 61:305-316. (Pubitemid 34075158)
4. Dogra GK, Herson H, Hutchinson B, Irish AB, Heath CH, Golledge C, Luxton G Moody H: Prevention of tunneled hemodi-alysis catheter-related infections using cath-eter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13: 2133-2139. (Pubitemid 34790791)
5. Nori US, Manohaharan A, Yee J, Besarab A: Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 2006; 48: 596-605. (Pubitemid 44402837)
6. Venditto M, Tezenas du Montcel S, Robert J, Trystam D, Dighiero J, Hue D, Bessette C, Deray G, Mercadal L: Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif 2010; 29: 268-273.
7. McIntyre CW, Hulme LJ, Taal M, Fluck RJ: Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66:801-805. (Pubitemid 38986971)
8. Kim SH, Song KI, Chang JW, Sim SB, Sung SA, Jo SK, Cho WY, Kim HK: Prevention of uncuffed hemodialysis catheter-related bac-teremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kid-ney Int 2006; 69:161-164. (Pubitemid 43117753)
9. Labriola L, Crott R, Jadoul M: Preventing he-modialysis-catheter bacteremia with an an-timicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008; 23: 1666-1672. (Pubitemid 351767750)
10. Saxena AK, Panhotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, Abu-Oun BA, Hussain SM, Al-Ghambi AA: Tunneled catheters' outcome optimization among diabetics on dialysis through antibi-otic-lock placement. Kidney Int 2006; 70: 1629-1635. (Pubitemid 44606999)
11. Allon M: Prophylaxis against dialysis cathe-ter-related bacteremia with a novel antimi-crobial lock solution. Clin Infect Dis 2003; 36: 1539-1544. (Pubitemid 36783336)
12. Betjes MGH, van Agteren M: Prevention of dialysis catheter-related sepsis with a cit-rate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19: 1546-1551.
13. Torres-Viera C, Thauvin-Eliopoulos C, Sou-li M, DeGirolami P, Farris MG, Wennersten CB, Sofia RD, Eliopoulos GM: Activities of taurolidine in vitro and in experimental en-terococcal endocarditis. Antimicrob Agents Chemother 2000; 44: 1720-1724. (Pubitemid 30340825)
14. Shah CB, Mittelam MW, Costerton JW, Par-enteau S, Pelak M, Arsenault R, Mermel LA: Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemoth-er 2002; 46:1674-1679. (Pubitemid 34535182)
15. Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R Schulz M, Diggle P: A randomized double-blind controlled trial of taurolidine-citrate cathe-ter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 2010; 55:1060-1068
16. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. The NKF Dialysis Outcomes Quality Initiative 'DOQI'. Am J Kidney Dis 2001; 37(suppl 1):S137-S181.
17. Weijmer MC, van den Dorpel MA, Van de Ven PJG, ter Wee PM, van Geelen JACA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CEH, Stas KJF, for the CITRATE Study Group: Randomized clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in he-modialysis patients. J Am Soc Nephrol 2005; 16:2769-2777.
18. Bleyer AJ, Mason L, Russell G, Raad II, Sher-ertz RJ: A randomized controlled trial of a new vascular catheter flush solution (mino-cycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005; 26: 520-524. (Pubitemid 40896141)
19. Jaffer Y, Selby NM, Taal MW, Fluck RJ, Mc-Intyre CW: A meta-analysis of hemodialysis locking solutions in the prevention of cathe-ter-related infection. Am J Kidney Dis 2008; 51: 233-241.
20. Allon M: Prophylaxis against hemodialysis catheter-related bacteremia: a glimmer of hope. Am J Kidney Dis 2008; 51: 165-168.
21. Riley B: Incompatibilities in intravenous so-lutions. J Hosp Pharm 1970; 28:228-240.
22. Abbas SA, Haloob IA, Taylor SL, Curry EM, King BB, Van der Merwe WM, Marshall MR: Effect of antimicrobial locks for tunneled he-modialysis catheters on bloodstream infec-tion and bacterial resistance: a quality im-provement report. Am J Kidney Dis 2009; 53: 492-502.
23. Saxena AK, Panhotra BR, Naguib M: Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacothera-py 2002; 22:105-108. (Pubitemid 34042395)
24. Moran JE, Ash SR, and the ASDNI Clini-cal Practice Committee: Locking solutions for hemodialysis catheters; heparin and cit-rate-a position paper by ASDIN. Semin Dial 2008; 21:490-492.
25. Power A, Duncan N, Singh S, Brown W, Dal-by E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D: Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 2009; 6:1034-1041.
26. Pronovost P, Needham D, Berenholtz S, Sin-opoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goe-schel C: An intervention to decrease cathe-ter-related bloodstream infections in the ICU. N Engl J Med 2006; 355: 2725-2732. (Pubitemid 46021509)